Thursday 5 December 2024 ,
Thursday 5 December 2024 ,
Latest News
From the Editor
Ageing is a process of gradual and spontaneous change, resulting in malnutrition through childhood, puberty and young adulthood and then decline of many…
Cancer - we need to change the conversation
When it comes to cancer, the media traditionally paints a picture of two extremes. It celebrates the outliers — like the person…
Ageing and health
People worldwide are living longer. Today, for the first time in history, most people can expect to live into their sixties and beyond. By 2050, the world’s…
The critical need to promote research of aging and aging-related diseases
Over the past decades, the average life expectancy has increased globally, reaching a world-wide average of about 70 years in 2014 (6 years longer than…
Lumbar disc prolapse: understanding and ways of prevention
Understanding of the back and disc prolapse : Disc prolapse also known as slipped disc is a medical condition affecting the spine…
Sepsis: When infection overwhelms
When I was a doctor in training I was involved in a very sad case, the unexpected death of a patient, a woman in her fifties who had diabetes.* She had…
Sugar addiction and its effects on health
Sugar Addiction doesn’t just lead to Obesity or Type-II Diabetes; it affects your Heart Health, Brain Function and even your Sexual Life. Do you…
Physiotherapy is one of the vital treatment options of patient in ICU
Dr. Bijoy Das. PT For mechanically ventilated patients, early physiotherapy has been shown to improve quality of life and to prevent ICU-associated complications…
25 years of Baby-Friendly Hospitals Initiative
This year marks the 25th anniversary of the Baby-Friendly Hospital Initiative (BFHI). Launched by WHO and UNICEF in 1991 following the Innocenti Declaration…
United Hospital observed World Heart Day
The theme of World Heart Day for the year 2016 is “Power your Life”. Our heart powers our whole body. It lets us love, laugh and live our…
FDA approves Amjevita (adalimumab-atto), a Biosimilar to Humira
The U.S. Food and Drug Administration today approved Amjevita (adalimumab-atto) as a biosimilar to Humira (adalimumab) for multiple inflammatory diseases.…
FDA approves Exondys 51 (eteplirsen) for Duchenne Muscular Dystrophy
The U.S. Food and Drug Administration today approved Exondys 51 (eteplirsen) injection, the first drug approved to treat patients with Duchenne muscular…
Most Viewed
- The critical need to promote research of aging and aging-related diseases
- Lumbar disc prolapse: understanding and ways of prevention
- Sugar addiction and its effects on health
- ICT, CRI sign MoU for ICT training to youths
- Policies required to develop tourism sector
- SDGs priorities in Bangladesh and the role of civil society
- FDA approves Exondys 51 (eteplirsen) for Duchenne Muscular Dystrophy
- Fire causes ‘huge damage’ to Benapole land port
- Shirin Shila signs new film
- JCI honours 10 outstanding young persons
Digital Edition
Copyright © All right reserved.
Editor : M. Shamsur Rahman
Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.
Editor : M. Shamsur Rahman
Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.
Disclaimer & Privacy Policy
....................................................
About Us
....................................................
Contact Us
....................................................
Advertisement
....................................................
Subscription
Powered by : Frog Hosting
